http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2016 Leerink Global Healthcare Conference
-
Sucampo Pharma (SCMP) Enters Option Agreement to License CPP-1X/Sulindac Product in North America
-
Sucampo Enters Into Exclusive Option and Collaboration Agreement With Cancer Prevention Pharmaceuticals for Development of Late-Stage CPP-1X/Sulindac Combination for Familial Adenomatous Polyposis
-
Sucampo Pharma (SCMP) Clarifies Previously Announced FY15, FY16 Guidance
-
Sucampo Provides Update to 2015 and Confirms 2016 Financial Guidance Post Closing of R-Tech Ueno Acquisition
-
Sucampo CEO Peter Greenleaf Appointed Chairman of the Board of Directors
-
Sucampo Pharma (SCMP) Announces Completion of $275M R-Tech Ueno Acquisition
-
Sucampo Completes Acquisition of R-Tech Ueno
-
Sucampo Completes Acquisition of R-Tech Ueno
-
Sucampo Announces Webcast of Its Presentation at Piper Jaffray 27th Annual Healthcare Conference
-
Sucampo Announces Webcast of Its Presentation at Piper Jaffray 27th Annual Healthcare Conference
-
Mast Therapeutics Announces Appointment Of Peter Greenleaf To Board of Directors
-
Sucampo Reports Third Quarter 2015 Financial Results and Provides Corporate Update
-
Sucampo Reports Third Quarter 2015 Financial Results and Provides Corporate Update
-
Sucampo Closes $250 Million Credit Facility
-
Sucampo Closes $250 Million Credit Facility
-
Sucampo Announces Third Quarter 2015 Earnings Call
-
Sucampo Announces Results of Tender Offer for R-Tech Ueno
-
Sucampo Announces Results of Tender Offer for R-Tech Ueno
-
Timothy P. Walbert Joins Sucampo's Board of Directors
-
Timothy P. Walbert Joins Sucampo's Board of Directors
-
Sucampo Launches Tender Offer to Acquire R-Tech Ueno
-
Sucampo Launches Tender Offer to Acquire R-Tech Ueno
-
Sucampo Reports Second Quarter 2015 Financial Results and Corporate Update
-
Sucampo Reports Second Quarter 2015 Financial Results and Corporate Update
-
Sucampo Announces Second Quarter 2015 Earnings Call
-
Sucampo Announces Second Quarter 2015 Earnings Call
-
Sucampo Announces Webcast of Its Presentation at Cantor Fitzgerald's Inaugural Healthcare Conference
-
Sucampo Announces Webcast of Its Presentation at Cantor Fitzgerald's Inaugural Healthcare Conference
-
China Food and Drug Administration Accepts IND for Pivotal Study of AMITIZA(R) (lubiprostone)
-
China Food and Drug Administration Accepts IND for Pivotal Study of AMITIZA(R) (lubiprostone)
-
Sucampo Announces Webcast of Its Presentation at the Jefferies 2015 Healthcare Conference
-
Sucampo Announces Webcast of Its Presentation at the Jefferies 2015 Healthcare Conference
-
Sucampo Announces Clinical Data on Lubiprostone to be Presented at Digestive Disease Week
-
Sucampo Announces Clinical Data on Lubiprostone to be Presented at Digestive Disease Week
-
Sucampo Announces Webcast of Its Presentation at the 2015 UBS Global Healthcare Conference
-
Sucampo Announces Webcast of Its Presentation at the 2015 UBS Global Healthcare Conference
-
Sucampo and Harbin Gloria Pharmaceuticals Enter Into Licensing Agreement for AMITIZA(R) (lubiprostone) in China
-
FDA Grants Fast Track Designation to Sucampo's Cobiprostone for Oral Mucositis
-
Sucampo Reports First Quarter 2015 Financial Results and Corporate Update
-
Sucampo Announces First Quarter 2015 Earnings Call
-
Sucampo Announces First Quarter 2015 Earnings Call
-
Sucampo Announces Webcast of Its Presentation at the 14th Annual Needham Healthcare Conference
-
Sucampo to Return All Licenses for Unoprostone Isopropyl to R-Tech Ueno
-
Sucampo to Return All Licenses for Unoprostone Isopropyl to R-Tech Ueno
-
Sucampo Reports Fourth Quarter and Full Year 2014 Financial Results and Corporate Update
-
Sucampo Announces Webcast of Its Presentation at the 27th Annual ROTH Conference
-
Sucampo Announces Webcast of Its Presentation at the 2015 Cowen and Company Healthcare Conference
-
Sucampo Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2014 Earnings Call
-
Sucampo Announces Resolution of Par Pharmaceutical's ANDA for RESCULA(R)

